Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: MS-H vaccine   

   This product is authorized under a different brandname in the EU in the folowing languages:
   - Ваксина MS-H (BG)
   - Vakcína MS-H (CS)
   - MS-H Vaccine (DA)
   - MS-H Impfstoff (DE)
   - MS-H Vaccine (EL)
   - MS-H Vaccine (ES)
   - MS-H vaktsiin (ET)
   - MS-H-rokote (FI)
   - Vaccin MS-H (FR)
   - MS-H vakcina (HU)
   - Vaccino MS-H (IT)
   - MS-H Vaccine (LT)
   - MS-H Vaccine (LV)
   - Vaċċine MS-H (MT)
   - MS-H Vaccin (NL)
   - MS-H Vaccine (PL)
   - Vacina MS-H (PT)
   - Vaccin MS-H (RO)
   - Vakcína MS-H (SK)
   - Cepivo MS-H (SL)
   - MS-H Vaccin (SV)
Auth. number : EU/2/11/126
INN : Mycoplasma synoviae Strain MS-H live attenuated thermosensitive
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI01 - Immunologicals for aves
Pharmacological subgroup: QI01A - Domestic fowl
Chemical subgroup: QI01AE - Live bacterial vaccines
Chemical substance: QI01AE03 - Mycoplasma
(See WHO ATCvet Index)
Indication: For active immunisation of future broiler breeder chickens, future layer breeder chickens and future layer chickens to reduce air sac lesions and reduce the number of eggs with abnormal shell formation caused by Mycoplasma synoviae.
Marketing Authorisation Holder: Pharmsure Ltd
Bewell House, Bewell St, Hereford HR4 0BA, United Kingdom

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/06/2011 Centralised - Authorisation EMEA/V/C/161 (2011)4296 of 14/06/2011
09/12/2011 Corrigendum
26/03/2014 Centralised - Variation EMEA/V/C/161/IA/6